Myelodysplasia: Differentiating neoplastic from nonneoplastic syndromes of ineffective hematopoiesis in dogs

Toxicologic Pathology

Volumn 31, Issue SUPPL., 2003, Pages 44-48

  Blue, Julia T ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Anemia; Dogs; Ineffective hematopoiesis; Myelodysplasia; Myelodysplastic syndromes; Neutropenia

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW CELL; CELL STRUCTURE; CLONAL VARIATION; COLONY FORMING UNIT GEMM; CONCEPT FORMATION; CONFERENCE PAPER; CYTOCHEMISTRY; CYTOGENETICS; DOG; DRUG METABOLISM; GENE MUTATION; HEMATOLOGY; HEMATOPOIESIS; IMMUNE RESPONSE; MALIGNANT TRANSFORMATION; MICROSCOPIC ANATOMY; MYELODYSPLASIA; NONHUMAN; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; SYNDROME DELINEATION; TERATOLOGY; TUMOR CELL; ARTICLE; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; CONCEPTUAL FRAMEWORK; HUMAN; MICROSCOPY; MORPHOLOGY; MULTIPOTENT STEM CELL; MYELODYSPLASTIC SYNDROME;

ANIMALIA; CANIS FAMILIARIS;

EID: 0037261419     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230390177659     Document Type: Conference Paper

References (26)

1. Alleman AR, Harvey JW (1993). The morphologic effects of vincristine sulfate on canine bone marrow cells. Vet Clin Pathol 22: 36-41.
2. Bartram CR (1996). Molecular genetic aspects of myelodysplastic syndromes. Semin Hematol 33: 139-149.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982). The French-American-British Co-operative Group Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189-199.
4. Blue JT, French TW, Kranz JS (1988). Non-lymphoid hematopoietic neoplasia in cats: A retrospective study of 60 cases. Cornell Vet 78: 21-42.
5. Claessens Y-E, Bouscary D, Dupont J-M, Picard F, Melle J, Gisselbrecht S, Lacombe C, Dreyfus F, Mayeux P, Fontenay-Roupe M (2002). In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: Evidence for Fas-dependent apoptosis. Blood 99: 1594-1601.
6. Couto CG, Kallet AJ (1984). Preleukemic syndrome in a dog. J Am Vet Med Assoc 184: 1389-1392.
7. Deldar A, Lewis H, Bloom J, Weiss L (1988). Cephalosporin-induced changes in the ultrastructure of canine bone marrow. Vet Pathol 25: 211-218.
8. Fenaux P, Morel P, Lai JL (1996). Cytogenetics of myelodysplastic syndromes. Semin Hematol 33: 127-138.
9. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999). World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 17: 3835-3849.
10. Harvey JW, Wolfshelmer KJ, Simpson CF, French TW (1985). Pathologic sideroblasts and siderocytes associated with chloroamphenicol therapy in a dog. Vet Clin Pathol 14: 36-42.
11. Heaney ML, Golde DW (1999). Myelodysplasia. New Engl J Med 340: 1649-1660.
12. Hisasue M, Okayama H, Okayama T, Suzuki T, Mizuno T, Fujino Y, Naganobu K, Hasegawa A, Watari T, Matsuki N, Kenichi M, Ohno K, Tsujimoto H (2001). Hematologic abnormalities and outcome of 16 cats with myelodysplastic syndromes. J Vet Intern Med 15: 471-477.
13. Jacobs G, Calvert C, Kaufman A (1998). Neutropenia and thrombocytopenia in three dogs treated with anticonvulsants. J Am Vet Med Assoc 212: 681-684.
14. Jain NC, Blue JT, Grindem CB, Harvey JW, Kociba GJ, Krehbiel JD, Lattimer KS, Raskin RE, Thrall MA, Zinkl JG (1991). Proposed criteria for classification of acute myeloid leukemia in dogs and cats. Vet Clin Pathol 20: 63-82.
15. Jandl JH (1996a). Megaloblastic anemias: Drug-induced suppression of DNA synthesis. In: Blood Textbook of Hematology, 2nd ed., Little, Brown and Company, Boston, Massachusetts, pp 277-279.
16. Jandl JH (1996b). Hypochromic anemias and disorders of iron metabolism: Drug-induced sideroblastic anemias. In: Blood Textbook of Hematology, 2nd ed., Little, Brown and Company, Boston, Massachusetts, pp 308-312.
17. Lichtman MA (2000). Myelodysplasia or myeloneoplasia: Thoughts on the nosology of clonal myeloid diseases. Blood Cells Mol Dis 26: 572-581.
18. Lorenz M, Evering WE, Provencher A, Blue JT, Lewis HB, Hazelette JR, Rajagopalan P, Meunier PC, Car BD (1999). Atypical antipsychotic-induced neutropenia in dogs. Toxicol Appl Pharmacol 155:227-236.
19. McManus PM, Hess RS (1998). Myelodysplastic changes in a dog with subsequent acute myeloid leukemia. Vet Clin Pathol 27: 112-115.
20. Miyamoto T, Horie T, Shimada T, Kuwamura M, Baba E (1999). Long-term case study of myelodysplastic syndrome in a dog. J Am Anim Hosp Assoc 35: 475-481.
21. Raskin RE (1996). Myelopoiesis and myeloproliferative disorders. Vet Clin North Am Small Anim Pract 26: 1023-1043.
22. Simon SR, Branda RF, Tindle BH, Burns SL (1988). Copper deficiency and sideroblastic anemia associated with zinc ingestion. Amer J Hematol 28: 181-183.
23. Stokol T, Blue JT, French TW (2000). Idopathic pure red cell aplasia and nonregenerative immune-mediated anemia in dogs: 43 cases (1988-1999). J Am Vet Med Assoc 216: 1429-1436.
24. Weiss DJ, Aird B (2001). Cytologic evaluation of primary and secondary myelodysplastic syndromes in the dog. Vet Clin Pathol 30: 67-75.
25. Weiss DJ, Lulich J (1999). Myelodysplastic syndrome with sideroblastic differentiation in a dog. Vet Clin Pathol 28: 59-63.
26. Weiss DJ, Raskin R, Zerbe C (1985). Myelodysplastic syndromes in two dogs. J Am Vet Med Assoc 187: 1038-1040.